// App-Quantinova.ai

EP566 : EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SUBCUTANEOUS IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: ADVANCE SC, A GLOBAL PHASE 3 CLINICAL TRIAL IN PROGRESS

Researchers

Presenter

  • Vickie McDonald

Principal Investigators

  • Catherine Broome

  • Shivi Jain

  • Sunil Babu

  • Esther Oliva

  • Wim Parys

  • Anna Hultberg

  • Kristof De Beuf

  • Domenica Gandini

  • Yoshitaka Miyakawa

  • Waleed Ghanima

Medical Centers

  • Barts Health NHS Trust, London, United Kingdom

  • Fort Wayne Medical Oncology and Hematology, Inc,Fort Wayne,United States

  • Ophthalmology, Grande Ospedale Metropolitano, Reggio Calabria, Italy

  • Saitama Medical University, Saitama, Japan

  • Loyola University Medical Center,Chicago,Verenigde Staten

  • Departments of Medicine, Hematology-Oncology, and Research, Østfold Hospital Trust, Kalnes, and the Department of Hematology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo,Oslo,Norway

  • Georgetown University, Washington D.C., DC, United States

  • argenx,Ghent,België

Locations

  • United Kingdom

  • United States

  • Italy

  • Japan

  • Norway

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Hyaluronidase

  • Fostamatinib

  • Dapsone

  • Danazol

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Pharmacokinetics

  • Pharmacodynamics

  • Fixed Dose

Phase

  • III

Study Id's

  • NCT03102593

  • NCT04687072

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved